BI
Biocept, Inc.
BIOCQ · OTC
$0.00 +0.00% (+$0.00)
1M +19,900.00%
Market Cap $525.0
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 7.52%
Rev. growth 67.24%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 123.69%
Gross margin 9.99%
FCF margin 54.51%
Quality
15 /100
Poor Asset turnover 0.84x
ROIC 117.56%
ROA 103.93%
Debt
62 /100
Moderate Int. coverage -100.94x
Debt/Equity 1.37x
Net debt/EBITDA 0.03x
Stability
1 /100
Unstable EPS volatility 564.88%
Beta 3.98x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BIOCQ
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Soon Kap Hahn
Employees
50
Headquarters
San Diego
Prihajajoči dogodki
24 NOV.
Earnings
Upcoming earnings report